Literature DB >> 29428565

Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome.

Shingen Nakamura1, Momoyo Azuma2, Tomoko Maruhashi3, Kimiko Sogabe3, Ryohei Sumitani3, Munenori Uemura3, Masami Iwasa3, Shiro Fujii3, Hirokazu Miki4, Kumiko Kagawa3, Takashi Hiraga5, Noriyasu Kondo5, Hiromi Fujita6, Fumihiko Mahara7, Masahiro Abe3.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). Clinical symptoms of SFTS often involve encephalopathy and other central neurological symptoms, particularly in seriously ill patients; however, pathogenesis of encephalopathy by SFTSV is largely unknown. Herein, we present case reports of three patients with SFTS, complicated by encephalopathy, admitted to Tokushima University hospital: one patient was a 63-year-old man, while the other two were 83- and 86-year-old women. All of them developed disturbance of consciousness around the 7th day post onset of fever. After methylprednisolone pulse therapy of 500 mg/day, all of them recovered without any neurological sequelae. SFTSV genome was not detected in the cerebrospinal fluid of 2 out of the 3 patients that were available for examination. In these patients, disturbance of consciousness seemed to be an indirect effect of the cytokine storm triggered by SFTSV infection. We propose that short-term glucocorticoid therapy might be beneficial in the treatment of encephalopathy during early phase of SFTSV infection.
Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Encephalopathy; Severe fever with thrombocytopenia syndrome; Steroid pulse therapy

Mesh:

Substances:

Year:  2018        PMID: 29428565     DOI: 10.1016/j.jiac.2017.11.004

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  10 in total

Review 1.  The Endless Wars: Severe Fever With Thrombocytopenia Syndrome Virus, Host Immune and Genetic Factors.

Authors:  Min Wang; Weilong Tan; Jun Li; Liqun Fang; Ming Yue
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

2.  Patient with severe fever with thrombocytopenia syndrome virus infection and central nervous system disturbance in Dongyang, Zhejiang Province, China, 2017.

Authors:  Yi Sun; Bin Guo; Hao Yan; Ai Lan Wu; Wen Wu Yao; Kang Chen; Jun Hang Pan; Zhao Xia Li; Hai Yan Mao; Yan Jun Zhang
Journal:  Virol J       Date:  2019-11-07       Impact factor: 4.099

3.  Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome.

Authors:  Fei Wang; Yunjuan Wu; Jie Jiao; Jun Wang; Zheng Ge
Journal:  Int J Gen Med       Date:  2020-12-30

Review 4.  Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development.

Authors:  Nathen E Bopp; Jaclyn A Kaiser; Ashley E Strother; Alan D T Barrett; David W C Beasley; Virginia Benassi; Gregg N Milligan; Marie-Pierre Preziosi; Lisa M Reece
Journal:  NPJ Vaccines       Date:  2020-12-17       Impact factor: 7.344

5.  Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study.

Authors:  Sook In Jung; Ye Eun Kim; Na Ra Yun; Choon-Mee Kim; Dong-Min Kim; Mi Ah Han; Uh Jin Kim; Seong Eun Kim; Jieun Kim; Seong Yeol Ryu; Hyun Ah Kim; Jian Hur; Young Keun Kim; Hye Won Jeong; Jung Yeon Heo; Dong Sik Jung; Hyungdon Lee; Kyungmin Huh; Yee Gyung Kwak; Sujin Lee; Seungjin Lim; Sun Hee Lee; Sun Hee Park; Joon-Sup Yeom; Shin-Woo Kim; In-Gyu Bae; Juhyung Lee; Eu Suk Kim; Jun-Won Seo
Journal:  PLoS Negl Trop Dis       Date:  2021-02-19

6.  The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.

Authors:  Lianzi Wang; Yang Xu; Shubing Zhang; Asma Bibi; Yuanhong Xu; Tao Li
Journal:  Front Cell Infect Microbiol       Date:  2022-02-08       Impact factor: 5.293

7.  Low serum free triiodothyronineis level predicts worse outcome of patients with severe fever with thrombocytopenia syndrome.

Authors:  Li Wang; Youde Liu; Haifeng Yu; Kun Ding; Zhiqiang Zou
Journal:  BMC Infect Dis       Date:  2022-04-20       Impact factor: 3.090

8.  Clinical features and epidemiology of severe fever with thrombocytopenia syndrome in dogs in the Republic of Korea: an observational study (2019-2020).

Authors:  Sun-Woo Han; Ye-In Oh; Ji-Min Rim; Yoon-Kyoung Cho; Dong-Hoo Kim; Jun-Gu Kang; Kyoung-Seong Choi; Joon-Seok Chae
Journal:  Vet Res Commun       Date:  2022-08-06       Impact factor: 2.816

9.  A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.

Authors:  Koichiro Suemori; Masayuki Saijo; Atsushi Yamanaka; Daisuke Himeji; Masafumi Kawamura; Takashi Haku; Michihiro Hidaka; Chinatsu Kamikokuryo; Yasuyuki Kakihana; Taichi Azuma; Katsuto Takenaka; Toru Takahashi; Akitsugu Furumoto; Toshiyuki Ishimaru; Masayuki Ishida; Masahiko Kaneko; Norimitsu Kadowaki; Kenichi Ikeda; Shigetoshi Sakabe; Tomohiro Taniguchi; Hiroki Ohge; Takeshi Kurosu; Tomoki Yoshikawa; Masayuki Shimojima; Masaki Yasukawa
Journal:  PLoS Negl Trop Dis       Date:  2021-02-22

Review 10.  Clinical Update of Severe Fever with Thrombocytopenia Syndrome.

Authors:  Jun-Won Seo; Dayoung Kim; Nara Yun; Dong-Min Kim
Journal:  Viruses       Date:  2021-06-23       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.